Upregulation of secreted aspartyl proteinase genes of fluconazole-sensitive Candida albicans isolates

Mol Biol Rep. 2019 Dec;46(6):6147-6154. doi: 10.1007/s11033-019-05049-2. Epub 2019 Oct 10.

Abstract

Candida albicans infection development depends on several factors associated with this etiological agent, including secreted aspartyl protease (Sap) production. Sap expression commonly occurs under selective pressure caused by the presence of antifungals. Fluconazole is the main antifungal drug used for treatment or prophylaxis. This study investigated the influence of inhibitory and sub-inhibitory fluconazole concentrations on Sap activity and their gene transcription for three clinical C. albicans isolates. Two isolates presented significant increases in Sap activity and transcription of SAP 1-8 genes in the presence of 1 MIC80 of fluconazole compared to the absence of the antifungal agent. The results suggest that the increase in Sap activity occurs due to an upregulation of the SAP gene transcription influenced by fluconazole. This suggests the importance of all SAP genes in the progression of bloodstream infections compared to primary tissue infection. However, this phenomenon does not occur everywhere, and it is multifactorial. This may be related to the selective pressure effect on transcription modulators. Although preliminary, these results open a new perspective for the study of virulence factors.

Keywords: Candida albicans; Fluconazole; Secreted aspartyl protease; Virulence factors.

MeSH terms

  • Aspartic Acid Proteases / genetics*
  • Candida albicans / drug effects*
  • Candida albicans / genetics*
  • Candida albicans / isolation & purification
  • Candidiasis / drug therapy
  • Candidiasis / microbiology*
  • Enzyme Activation
  • Fluconazole / pharmacology*
  • Gene Expression Regulation, Enzymologic / drug effects*
  • Gene Expression Regulation, Fungal / drug effects*
  • Humans
  • Microbial Sensitivity Tests

Substances

  • Fluconazole
  • Aspartic Acid Proteases